Wealthfront Advisers LLC lowered its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 84.4% during the fourth quarter, according to the company in its most recent disclosure with the ...

The financial services giant Goldman Sachs is telling shareholders that its competitors are now offering crypto products and ...

Evercore ISI set a $50.00 price target on Moderna in a research note on Friday, February 14th. The Goldman Sachs Group downgraded Moderna from a “buy” rating to a “neutral” rating and ...

Improving economic conditions and a more favorable regulatory environment give Goldman Sachs catalysts to benefit from in the near term. Investors shouldn't expect the stock's trailing-five-year ...

Goldman Sachs named David Dubner as chief operating officer of global mergers and acquisitions, according to a memo seen by Reuters on Wednesday, beefing up leadership in one of its most important ...

Goldman Sachs Asset Management is trying to serve more investors looking for downside protection from market turmoil. Bryon ...